Analytical services : (a) means a facility in possession of prescription drugs for the purpose of analysis; and (b) does not include a laboratory possessing prescription drugs used as standards and controls in performing drug monitoring or drug screening analysis if the prescription drugs are pre-diluted in a human or animal body fluid, human or animal body fluid components, organic solvents, or inorganic buffers at a concentration not exceeding one milligram per milliliter when labeled or otherwise designated as being for in-vitro diagnostic use. (3) “Central Order Entry” means a pharmacy where functions are performed at the request of another pharmacy to perform processing functions such as dispensing, drug review, refill authorizations, and therapeutic interventions. (4) “Drugs”, as used in this[ese] rule[s], means drugs or devices. (5) “Dispense”, as defined in Subsection 58-17b-102(23), does not include transferring medications for a patient from a legally dispensed prescription for that particular patient into a daily or weekly drug container to facilitate the patient taking the correct medication.
(6) “Drug therapy management” means the review of a drug therapy regimen of a patient by one or more pharmacists for the purpose of evaluating and rendering advice to one or more practitioners regarding adjustment of the regimen. (7) “High-risk, medium-risk, and low-risk drugs” refers to the risk to a patient’s health from compounding sterile preparations, as referred to in USP-NF Chapter 797, for details of determining risk level. (8) “Hospice facility pharmacy” means a pharmacy that supplies drugs to patients in a licensed healthcare facility for terminal patients. (9) “Hospital clinic pharmacy” means a pharmacy that is located in an outpatient treatment area where a pharmacist or pharmacy intern is compounding, admixing, or dispensing prescription drugs, and where: (a) prescription drugs or devices are under the control of the pharmacist, or the facility for administration to patients of that facility; (b) prescription drugs or devices are dispensed by the pharmacist or pharmacy intern; or (c) prescription drugs are administered in accordance with the order of a practitioner by an employee or agent of the facility. (10)
“Legend drug” means any drug or device that has been determined to be unsafe for self-medication or any drug or device that bears or is required to bear the legend: (a) “Caution: federal law prohibits dispensing without prescription”; (b) “Caution: federal law restricts this drug to use by or on the order of a licensed veterinarian”; or (c) “Rx only”. (11) “Maintenance medications” means medications the patient takes on an ongoing basis. (12) “MPJE” means the Multistate Jurisprudence Examination. (13) “NABP” means the National Association of Boards of Pharmacy. (14) “NAPLEX” means North American Pharmacy Licensing Examination. (15) “Parenteral” means a method of drug delivery injected into body tissues but not via the gastrointestinal tract.